Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Multipronged approach eliminated treatment gaps between black and white patients and improved overall treatment rates.
But, despite the difference, the risk of dying from the disease is still small.
Black women face additional burdens along their risk-management journey, researchers say.
New UCSF study analyzes prostate cancer deaths by race.
Less than 5 percent of Black patients were involved in trials for 24 out of 31 cancer drugs approved since 2015.
Studies show African-American men may respond better to treatment and survive longer.
Insurance accounts for 37 percent of the total excess risk of death in Black patients, study finds.
At a major transplant center in Indiana, despite similar levels of liver disease severity, Blacks had a lower transplant rate than whites.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.